This inventor holds 2 USPTO granted patents. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1999.
Location History:
- Englewood, AL (US) (1999)
- Homewood, AL (US) (1999)
Company Filing History:
Years Active: 1999
Title: David Raben: Innovator in Targeted Radiotherapy
Introduction
David Raben is a notable inventor based in Englewood, Alabama, who has made significant contributions to the field of targeted radiotherapy. With a focus on enhancing the specificity of radioisotope localization at tumor sites, Raben has developed innovative methods that leverage gene therapy technology. His work aims to improve treatment outcomes for individuals in need of targeted cancer therapies.
Latest Patents
David Raben holds 2 patents related to his groundbreaking work. His latest patents include a method for genetic induction of receptors for targeted radiotherapy. This invention provides a method to achieve radioisotopic localization at tumor sites. The process involves transducing the tumor with a gene encoding a membrane-expressed protein unique to the tumor and administering a radiolabeled ligand that specifically binds to this protein. The use of gene therapy technology to induce expression of high-affinity membrane molecules enhances the specificity of radioisotope localization, while radioactive isotopes can deliver radiation damage across several cell diameters, compensating for less than perfect transduction efficiency.
Career Highlights
David Raben is associated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this esteemed institution has allowed him to explore innovative solutions in cancer treatment, particularly in the realm of targeted therapies. His research has the potential to significantly impact the effectiveness of radiotherapy for cancer patients.
Collaborations
David Raben has collaborated with notable colleagues in his field, including Donald J Buchsbaum and Murray A Stackhouse. These collaborations have fostered a rich environment for innovation and have contributed to the advancement of targeted radiotherapy techniques.
Conclusion
David Raben's contributions to the field of targeted radiotherapy exemplify the power of innovation in medicine. His patents and research efforts are paving the way for more effective cancer treatments, showcasing the importance of continued exploration in this vital area of healthcare.